维普中文期刊产品整合服务
23篇 您的检索式:作者名="Degn B"
    题名 作者 年代 出处 被引量
1Research of enhancing cultivate quality of medical graduates 显示文摘DEGN B CHEN LZ WU LX 2000China Journal of Modern Medicine2000,10,10:1
2One week′s treatment with the long-acting glucagon-like peptide 1 derivative liraglutide(NN2211) markedly improves 24-h glycemia andα-and β-cell function and reduces endogenous glucose release in patients with type 2 diabetes显示文摘DEGN K B CLAUS B J JEPPE S 0,,05:1
3Effects of the long _ actinghuman glucagon - like peptide - 1 analog liraglutide on p - cellfunction in normal living conditions 显示文摘Marl A Degn K Brock B 2007Diabetes Care2007,30,8:1
4One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha-and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes显示文摘Degn K B Juhl C B Sturis J 2004Diabetes2004,53,5:1
5One week's treatment with the long-acting glucagon-Iike peptide 1 derivative liraglutide (NN2211) markedly improves 24h glycemia and alpha-and be- ta-cell function and reduces endogenous glucose release in pa- tients with type 2 diabetes显示文摘Degn K B Juhl C B Sturis J 2010Diabetes2010,53,5:1
6Effect of intravenous infusion of exenatide ( synthetic exendin4 ) on glucose-dependent insulin secretion and counterregulation during hypoglycemia 显示文摘Degn KB Brock B Juhl CB 2004Diabetes2004,53,9:1
7Preimplantation genetic diagnosis for HLA typing in a case of X-linked chronic gran?ulomatous disease显示文摘Degn B Hindkjaer 1 Christensen MW 2012Acta Obstet Gynecol Scand2012,91,7:1
8Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose- dependent insulin secretion and counterregulation during hypoglycemia显示文摘Degn KB Brock B Juhl CB 2004Diabetes2004,53,9:1
9Effects of the long-acting human glucagon-like peptide-I analog liraglutide on 13-cell function in normal living conditions 显示文摘Mart A Degn K Brock B 2007Diabetes Care2007,30,8:1
10Effect of intravenous infusion of exenatide (synthetic exendin4) on glucose-dependent insulin secretion and counter regulation during hypoglycaemia显示文摘DEGN K B BROCK B JUHL C B 2004Diabetes2004,53,:1
11One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide ( NN2211 ) markedly improves 24 h glycemia and α- and β-cell function and reduces endogenous glucose release in patients with type 2 diabetes 显示文摘Degn K B Juhl C B Sturis J 2004Diabetes2004,53,5:1
12Effect of intravenous infusion of exenatide(synthetic exendin-4) on glucose-dependent insulin secretion and counterregulationduring hypoglycemia显示文摘Degn K B Brock B Juhl C B 2004Diabetes2004,53,9:1
13Effect of intravenous infusion of exenatide(synthetic exendin-4)on glucose-dependent insulin secretion and counterregulation during hypoglycemia显示文摘Degn KB Brock B Juhl CB 2004Diabetes2004,53,9:1
14Effects of the long - acting human glucagon -like peptide - 1 analog liraglutide on beta - cell function in normal living conditions 显示文摘Marl A Degn K Brock B 2007Diabetes Care2007,30,8:1
15Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia显示文摘Degn KB Brock B Juhl CB 0,,:1
16Ethanol re-assimilation and ethanol tolerance in Pichia stipitis CBS 6054 studied by 13C NMR spectroscopy显示文摘SKOOG K DEGN H HAHN-HGERDAL B 1992Applied and Environmental Microbiology1992,58,8:1
17Effect of intravenous inth- sion of exenatide ( synthetic exendin4) on glucose-dependent in- sulin secretion and eounterregulation during hypoglycemia 显示文摘Degn KB Brock B Juhl CB 2004Diabetes2004,53,9:1
18Effect of intravertous infusion of exenatide (synthetic exendin-4) on glucose- dependent insulin screetion and counter regulation during hypoglycemia 显示文摘Degn K B Brock B Juhl C B 2004Diabetes2004,53,:1
19Effect of intravenous infusion of exenatide(synthetic exendin-4)on glucose-dependent insulin secretion and counterregulation during hypoglycemia 显示文摘Degn K_B Brock B Juhl CB 2004Diabetes2004,53,9:1
20Effect of intravenous infusion of exenatide ( synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia 显示文摘Degn K B Brock B Juhl C B 2004Diabetes2004,53,9:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费